Cargando…
The efficacy and safety of Niaoduqing granules in the treatment of diabetic kidney disease: a systematic review and meta-analysis
Background: Diabetic nephropathy (DN) is the main cause of chronic kidney disease (CKD) and end-stage renal failure (ESRF), and the control of disease progression and adverse events during treatment needs to be improved. Objective: This study aimed to systematically evaluate the clinical efficacy an...
Autores principales: | Song, Chaoqun, Zhu, Zhiyue, Liu, Le, Liu, Shilin, Li, Yuandong, Xiao, Yang, Wu, Chunwei, Nan, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354524/ https://www.ncbi.nlm.nih.gov/pubmed/37475716 http://dx.doi.org/10.3389/fphar.2023.1180751 |
Ejemplares similares
-
Effects of Niaoduqing granules on inflammatory response of diabetic kidney disease: A meta‑analysis
por: Zhou, Peipei, et al.
Publicado: (2023) -
Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis
por: Zhu, Zhiyue, et al.
Publicado: (2022) -
NiaoDuQing granules relieve chronic kidney disease symptoms by decreasing renal fibrosis and anemia
por: Wang, Xu, et al.
Publicado: (2017) -
Clinical efficacy and safety of Xuefu Zhuyu decoction in the treatment of diabetic kidney disease: A protocol for systematic review and meta-analysis
por: Song, Chaoqun, et al.
Publicado: (2022) -
Niaoduqing alleviates podocyte injury in high glucose model via regulating multiple targets and AGE/RAGE pathway: Network pharmacology and experimental validation
por: Fang, Yipeng, et al.
Publicado: (2023)